10 January 2024

You will join our laboratory of Translational Research in Neuromuscular Diseases at the Institut de Recerca Sant Joan de Déu-Hospital Sant Joan de Déu Barcelona (https://www.irsjd.org/es/investigacion/5/investigacion-aplicada-en-enfermedades-neuromusculares).  You will lead a project with the overall aim of investigating the application of gene and base editing strategies using various CRISPR /Cas9 and RNA-based systems for the correction of mutations in collagen VI genes that result in a severe form of congenital muscular dystrophy.

Their Institute is a leading biomedical research hub in Europe for rare diseases and one of the largest pediatric Hospitals in the world. They are a multidisciplinary group recognized as a reference centre for neuromuscular diseases working with an extensive network of collaborators inside and outside Europe. They participate in several clinical trials for various neuromuscular and neurological conditions.

If you want to be part of an exciting story and help to develop life-changing therapies for rare diseases this could be your opportunity.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern